• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Model Number GBF0508
Device Problem Off-Label Use (1494)
Patient Problems Foreign Body Reaction (1868); Patient Problem/Medical Problem (2688)
Event Type  Injury  
Manufacturer Narrative
Per the reporter, medical intervention (surgery) is primarily required to resolve a large lump that developed after off-label bellafill dermal filler injection in the jawline.As of this submission, it is unknown if the surgery has been done yet; however it is planned along with an expected facelift revision.The bellafill injection occurred in (b)(6) 2017.An exact date was not provided.The patient was injected on the same day off-label in the bilateral jawline, both cheeks, and both temples.No issues were reported in the other areas injected.The lump is on one side of the jawline.An exact date for onset of the lump was not provided, but is suspected to be b)(6) 2019.Suneva conducted a review of the lot used in the patient's procedure, lot f161091.No issues were found.The lot was manufactured according to approved work instructions and met all acceptance criteria upon release.The lot expired on 11/24/2017; therefore, retained lot samples were not available for review.Bellafill syringes are single use devices that are typically discarded after use.Per the bellafill ifu: "the syringe and any unused material should be discarded after a single treatment visit." bellafill dermal filler is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.Lumps are anticipated patient events that are documented in the bellafill instructions for use.Clinical studies support that these issues may resolve over time with or without treatment.
 
Event Description
Medical intervention (surgery) required to resolve a large lump on the jawline that developed after bellafill dermal filler injection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BELLAFILL DERMAL FILLER
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer (Section G)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer Contact
stacy lewis
5870 pacific center blvd.
san diego, CA 92121
8587685492
MDR Report Key9130796
MDR Text Key165760110
Report Number3003707320-2019-00017
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 09/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/24/2017
Device Model NumberGBF0508
Device Catalogue NumberGBF0508
Device Lot NumberF161091
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/29/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-